title: Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation.
abstract: Mitogen-activated protein (MAP) kinases are stable enzymes that are mainly regulated by phosphorylation and subcellular targeting. Here we report that extracellular signal-regulated kinase 3 (ERK3), unlike other MAP kinases, is an unstable protein that is constitutively degraded in proliferating cells with a half-life of 30 min. The proteolysis of ERK3 is executed by the proteasome and requires ubiquitination of the protein. Contrary to other protein kinases, the catalytic activity of ERK3 is not responsible for its short half-life. Instead, analysis of ERK1/ERK3 chimeras revealed the presence of two destabilization regions (NDR1 and -2) in the N-terminal lobe of the ERK3 kinase domain that are both necessary and sufficient to target ERK3 and heterologous proteins for proteasomal degradation. To assess the physiological relevance of the rapid turnover of ERK3, we monitored the expression of the kinase in different cellular models of differentiation. We observed that ERK3 markedly accumulates during differentiation of PC12 and C2C12 cells into the neuronal and muscle lineage, respectively. The accumulation of ERK3 during myogenic differentiation is associated with the time-dependent stabilization of the protein. Terminal skeletal muscle differentiation is accompanied by cell cycle withdrawal. Interestingly, we found that expression of stabilized forms of ERK3 causes G(1) arrest in NIH 3T3 cells. We propose that ERK3 biological activity is regulated by its cellular abundance through the control of protein stability.
authors.affiliation: Institut de Recherches Cliniques de Montréal, Université de Montréal, Montreal, Quebec H2W 1R7, Canada.
authors.forename: Philippe
authors.initials: P
authors.lastname: Coulombe
authors.forename: Geneviève
authors.initials: G
authors.lastname: Rodier
authors.forename: Stéphane
authors.initials: S
authors.lastname: Pelletier
authors.forename: Johanne
authors.initials: J
authors.lastname: Pellerin
authors.forename: Sylvain
authors.initials: S
authors.lastname: Meloche
mesh_terms: D016475:3T3 Cells; D000818:Animals; D042846:CDC2-CDC28 Kinases; D002454:Cell Differentiation; D018844:Cyclin-Dependent Kinases / Q000378:metabolism; D003546:Cysteine Endopeptidases / Q000378:metabolism*; D006367:HeLa Cells; D006801:Humans; D020935:MAP Kinase Signaling System; D051379:Mice; D008807:Mice, Inbred BALB C; D048053:Mitogen-Activated Protein Kinase 6 / Q000737:chemistry / Q000378:metabolism*; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D016196:S Phase; D013997:Time Factors; D014157:Transcription Factors / Q000378:metabolism; D014162:Transfection; D025801:Ubiquitin / Q000378:metabolism*
chemical_list: D011993:Recombinant Fusion Proteins; D014157:Transcription Factors; D025801:Ubiquitin; D042846:CDC2-CDC28 Kinases; D018844:Cyclin-Dependent Kinases; D048053:Mitogen-Activated Protein Kinase 6; D003546:Cysteine Endopeptidases